Another strong year for novel drug approvals is in the making

Another strong year for novel drug approvals is in the making

Source: 
EP Vantage
snippet: 

A handful of unexpected knockbacks by the FDA this year had biopharma followers wondering whether the US regulator had sharpened its teeth. The raw numbers do not seem to support this idea, with 45 novel agents having received a green light so far in 2020, only four fewer than last year’s total.